Averitas Pharma is proud to support organizations, investigators and individuals who support our patient population of those living with pain.
If you are interested in submitting an application for an investigator-initiated study or educational grant, please download the following forms and send your completed proposal to grants@averitaspharma.com for grants and
iis@averitaspharma.com for investigator-initiated studies.
While Averitas recognizes the important work that your request is intended to fund, please note that Averitas has limited funding available to support such requests and regrets that not all requests can be fulfilled. Prior to submitting an application, please consider the following:
All requests for funding must be submitted at least 60 days before the start date of the activity
Averitas’ Grants and IIS Committees meet once a month to evaluate applications
All submissions are final, will be evaluated against internally defined objective criteria, and must align with Averitas’ scientific areas of interest
You will receive an email notification from Averitas if additional information is required
You will receive Averitas’ decision via email. If approved, the authorized signatory will receive the required documentation (i.e. Grant or IIS Agreement) electronically
Both grants and IISs must reconcile and present final reports after activities are concluded
Averitas prioritizes requests to make the strongest impact in our patient populations. Therefore, applications from organizations and individuals with a primary focus in peripheral neuropathic pain and osteoarthritis of the knee will be considered. Funding determinations are made based solely on the scientific merit of the proposals as they align to our priorities, and no consideration is given to past, present, or future business with the recipient individuals and organizations (i.e., we will not take into account recipients' prescribing or recommending of Averitas products).
If you require assistance please contact grants@averitaspharma.com for grants or iis@averitaspharma.com for IISs.
Grants
IIS
You are now leaving the Averitas Pharma Website